Digbi News
Digbi Health Selected by Shortlister as a Q3 2025 Top Vendor in Obesity Management, Diabetes Management and GI Health
Recognized for ten consecutive quarters by the leading marketplace employers and consultants use to find providers in the wellbeing and benefits sector.
July 27, 2025 /Digbi News/ -- We're proud to announce that Digbi Health has been selected as a Q3 2025 Top Vendor for Weight Management, Diabetes Management, and Digestive Health by Shortlister — the leading marketplace for employers and consultants to find providers in the wellbeing and benefits sector — for ten consecutive quarters.
This recognition highlights our mission to bring Precision Biology-based innovation to empower employers in the US and around the world to address the top four food-related illnesses through a food-as-medicine first approach.
Our team is dedicated to a person-centered approach to employee health, helping employers consolidate point solutions with a focus on patient-centric care rather than process-centric strategies.
As a top vendor for ten quarters, Shortlister acknowledges our performance in supporting the overall health of employees and organizations, as well as our commitment to customer centricity.
Interested in exploring our award-winning services, and why employers and consultants consistently rank us first? Reach out at digbi@digbihealth.com.
About Digbi Health
Digbi Health is the precision biology care company unifying metabolic and inflammatory care — including obesity, cardiometabolic, gastrointestinal, and inflammatory disorders. These illnesses share a root cause: a mismatch between an individual's biology and the one-size-fits-all lifestyle guidance they've been given. Digbi combines the gut microbiome, genetics, advanced blood biomarkers, and continuous digital health data to build a unique biological profile for each individual and identify what is driving their disease. AI then personalizes lifestyle treatment and, when needed, clinical treatment, delivered through the first precision-biology AI-orchestrated national telehealth platform. Through Digbi Labs, we invest in our vision of making chronic illness optional and advancing healthspan — partnering with leading universities, pharmaceutical companies, and scientific and clinical laboratories, running distributed human trials and publishing peer-reviewed research on genetics, the gut microbiome, and the use of AI to deliver care that is safe, cost-effective, and accessible. Digbi's healthcare cost reduction is documented in multiple peer-reviewed actuarial claims studies. Digbi is accessible to 30 million individuals through more than 300 employers and health plans.
SOURCE Digbi Health
- Shortlister
- Awards
- Obesity Management
- Diabetes Management
- Digestive Health